Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
27.52
-0.83 (-2.93%)
Feb 21, 2025, 4:00 PM EST - Market closed

Apellis Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019 2018 - 2014
Period Ending
Feb '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
3,4237,0935,7184,6034,3321,956
Upgrade
Market Cap Growth
-21.59%24.06%24.22%6.25%121.45%163.70%
Upgrade
Enterprise Value
3,4906,7375,1234,3853,9771,676
Upgrade
Last Close Price
27.5259.8651.7147.2857.2030.62
Upgrade
PS Ratio
4.7417.8975.8169.1517.28-
Upgrade
PB Ratio
14.1736.4733.6623.1721.1857.15
Upgrade
P/TBV Ratio
14.8136.4733.6623.1721.1857.15
Upgrade
EV/Sales Ratio
4.8816.9967.9265.8715.87-
Upgrade
Debt / Equity Ratio
1.980.570.661.061.854.59
Upgrade
Asset Turnover
0.830.510.090.070.37-
Upgrade
Inventory Turnover
3.413.156.35---
Upgrade
Quick Ratio
3.602.343.565.937.035.35
Upgrade
Current Ratio
4.363.104.296.257.155.67
Upgrade
Return on Equity (ROE)
-106.56%-290.14%-353.93%-370.20%-288.86%-312.20%
Upgrade
Return on Assets (ROA)
-16.23%-41.73%-45.27%-36.39%-19.79%-60.73%
Upgrade
Return on Capital (ROIC)
-26.60%-109.93%-107.49%-67.63%-34.54%-94.92%
Upgrade
Earnings Yield
-7.31%-7.45%-11.41%-16.21%-7.96%-15.58%
Upgrade
FCF Yield
-6.01%-8.40%-9.01%-12.26%-3.83%-10.88%
Upgrade
Buyback Yield / Dilution
-6.08%-11.84%-25.70%-12.32%-20.78%-14.40%
Upgrade
Total Shareholder Return
-6.08%-11.84%-25.70%-12.32%-20.78%-14.40%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.